Resources

Founded in 2010 and based in Paris, Invectys is a biopharmaceutical company focused on the development of innovative immunotherapy approaches to treat cancer.

Invectys exploits a novel approach to mobilizing and restoring the anti-tumor capacity of the immune system of cancer patients. This allows virtually all cancers to be targeted. Invectys focuses its efforts on the universal tumor antigen telomerase that is critical to uncontrolled cell growth.

Menu

Contact us
Legal notices
Press Releases

Contact US

Paris Biopark
12 rue Jean Antoine de Baïf
F – 75013 PARIS

Facebook
Google+
Twitter
LinkedIn

Credits

Communication and editorial: Acorelis
Graphic creation and development: 17Pixel.com